March 2016

March 2016

In this issue, our upfront topics range from a fighting flu with imitation antibodies, to pharma cargo stolen by the Italian mafia. Our feature discusses LEO Pharma’s Open Innovation platform – the winner of our Innovation Awards. In best practice, four scientists tell us how new spectroscopic sensors can streamline bioprocess monitoring to better meet FDA standards. In NextGen, we speak with John Salafsky about a new technique to see protein conformational changes in real time, which could open up new screening options for drug discovery; and we Sit Down With Keith Thompson, CEO of the Cell and Gene Therapy Catapult, UK.

Recent Issues